Bédard PJ - Search Results

1

Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.

Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bédard PJ, Di Paolo T. Calon F, et al. Among authors: bedard pj. Brain Res. 1995 May 22;680(1-2):43-52. doi: 10.1016/0006-8993(95)00229-j. Brain Res. 1995. PMID: 7663983

2

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.

Calon F, Morissette M, Ghribi O, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T. Calon F, et al. Among authors: bedard pj. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):127-38. doi: 10.1016/s0278-5846(01)00237-8. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11853103

3

Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.

Calon F, Morissette M, Rajput AH, Hornykiewicz O, Bédard PJ, Di Paolo T. Calon F, et al. Among authors: bedard pj. Mov Disord. 2003 Mar;18(3):241-253. doi: 10.1002/mds.10343. Mov Disord. 2003. PMID: 12621627

4

Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.

Calon F, Dridi M, Hornykiewicz O, Bédard PJ, Rajput AH, Di Paolo T. Calon F, et al. Among authors: bedard pj. Brain. 2004 May;127(Pt 5):1075-84. doi: 10.1093/brain/awh128. Epub 2004 Mar 19. Brain. 2004. PMID: 15033896

5

Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.

Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T. Morissette M, et al. Among authors: bedard pj. Synapse. 2006 Sep 1;60(3):239-50. doi: 10.1002/syn.20295. Synapse. 2006. PMID: 16739115

6

Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.

Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T. Gagnon C, et al. Among authors: bedard pj. Brain Res. 1991 Sep 6;558(2):251-63. doi: 10.1016/0006-8993(91)90776-r. Brain Res. 1991. PMID: 1838295

7

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.

Gagnon C, Bédard PJ, Di Paolo T. Gagnon C, et al. Among authors: bedard pj. Eur J Pharmacol. 1990 Mar 13;178(1):115-20. doi: 10.1016/0014-2999(90)94802-5. Eur J Pharmacol. 1990. PMID: 1970537

8

Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.

Rouillard C, Bédard PJ, Di Paolo T. Rouillard C, et al. Among authors: bedard pj. Eur J Pharmacol. 1990 Aug 28;185(2-3):209-15. doi: 10.1016/0014-2999(90)90642-j. Eur J Pharmacol. 1990. PMID: 2253695

9

[Animal models of tardive dyskinesia].

Bédard PJ, Boucher R, DiPaolo T. Bédard PJ, et al. Encephale. 1988 Sep;14 Spec No:163-6. Encephale. 1988. PMID: 2905644 Review. French.

10

Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.

Falardeau P, Bédard PJ, Di Paolo T. Falardeau P, et al. Among authors: bedard pj. Neurosci Lett. 1988 Mar 31;86(2):225-9. doi: 10.1016/0304-3940(88)90575-7. Neurosci Lett. 1988. PMID: 2966905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters